-
Alvarez C P, Lasala F, Carrillo J. C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans[J]. J Virol, 2002, 76(): 6841-6844. doi: 10.1128/JVI.76.13.6841-6844.2002
-
Basu A, Li B, Mills D M. Identification of a small-molecule entry inhibitor for filoviruses[J]. J Virol, 2011, 85(): 3106-3119. doi: 10.1128/JVI.01456-10
-
Brindley M A, Hughes L, Ruiz A. Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events[J]. J Virol, 2007, 81(): 7702-7709. doi: 10.1128/JVI.02433-06
-
Chan S Y, Empig C J, Welte F J. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses[J]. Cell, 2001, 106(): 117-126. doi: 10.1016/S0092-8674(01)00418-4
-
Chandran K, Sullivan N J, Felbor U. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection[J]. Science, 2005, 308(): 1643-1645. doi: 10.1126/science.1110656
-
Connor R I, Chen B K, Choe S. Vpr is required for efficient replication of human immunodefi-ciency virus type-1 in mononuclear phagocytes[J]. Virology, 1995, 206(): 935-944. doi: 10.1006/viro.1995.1016
-
Dolnik O, Volchkova V, Garten W. Ectodomain shedding of the glycoprotein GP of Ebola virus[J]. Embo J, 2004, 23(): 2175-2184. doi: 10.1038/sj.emboj.7600219
-
Dube D, Schornberg K L, Shoemaker C J. Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry[J]. Proc Natl Acad Sci USA, 2010, 107(): 16637-16642. doi: 10.1073/pnas.1008509107
-
Ebert D H, Deussing J, Peters C. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells[J]. J Biol Chem, 2002, 277(): 24609-24617. doi: 10.1074/jbc.M201107200
-
Feldmann H, Volchkov V E, Volchkova V A. Biosynthesis and role of filoviral glycoproteins[J]. J Gen Virol, 2001, 82(): 2839-28348. doi: 10.1099/0022-1317-82-12-2839
-
He J, Choe S, Walker R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity[J]. J Virol, 1995, 69(): 6705-6711.
-
Huang I C, Bosch B J, Li F. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells[J]. J Biol Chem, 2006, 281(): 3198-3203. doi: 10.1074/jbc.M508381200
-
Ito H, Watanabe S, Takada A. Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies[J]. J Virol, 2001, 75(): 1576-1580. doi: 10.1128/JVI.75.3.1576-1580.2001
-
Jeffers S A, Sanders D A, Sanchez A. Covalent modifications of the ebola virus glycoprotein[J]. J Virol, 2002, 76(): 12463-12472. doi: 10.1128/JVI.76.24.12463-12472.2002
-
Jiang H, Wang J, Manicassamy B. The role of the charged residues of the GP2 helical regions in Ebola entry[J]. Virol Sin, 2009, 24(): 121-135. doi: 10.1007/s12250-009-3015-6
-
Kaletsky R L, Simmons G, Bates P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity[J]. J Virol, 2007, 81(): 13378-13384. doi: 10.1128/JVI.01170-07
-
Kuhn J H, Radoshitzky S R, Guth A C. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor[J]. J Biol Chem, 2006, 281(): 15951-15958. doi: 10.1074/jbc.M601796200
-
Lee J E, Fusco M L, Hessell A J. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor[J]. Nature, 2008, 454(): 177-182. doi: 10.1038/nature07082
-
Leffel E K, Reed D S. Marburg and Ebola viruses as aerosol threats[J]. Biosecur Bioterror, 2004, 2(): 186-191. doi: 10.1089/bsp.2004.2.186
-
Leroy E M, Kumulungui B, Pourrut X. Fruit bats as reservoirs of Ebola virus[J]. Nature, 2005, 438(): 575-576. doi: 10.1038/438575a
-
Leroy E M, Rouquet P, Formenty P. Multiple Ebola virus transmission events and rapid decline of central African wildlife[J]. Science, 2004, 303(): 387-390. doi: 10.1126/science.1092528
-
Lin G, Simmons G, Pohlmann S. Differential N-linked glycosylation of human im-munodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR[J]. J Virol, 2003, 77(): 1337-1346. doi: 10.1128/JVI.77.2.1337-1346.2003
-
Manicassamy B, Rong L. Expression of Ebolavirus glycoprotein on the target cells enhances viral entry[J]. Virol J, 2009, 6(): 75-. doi: 10.1186/1743-422X-6-75
-
Manicassamy B, Wang J, Jiang H. Comprehensive Analysis of Ebola Virus GP1 in Viral Entry[J]. J Virol, 2005, 79(): 4793-4805. doi: 10.1128/JVI.79.8.4793-4805.2005
-
Manicassamy B, Wang J, Rumschlag E. Characterization of Marburg virus glycoprotein in viral entry[J]. Virology, 2007, 358(): 79-88. doi: 10.1016/j.virol.2006.06.041
-
Mpanju O M, Towner J S, Dover J E. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry[J]. Virus Res, 2006, 121(): 205-214. doi: 10.1016/j.virusres.2006.06.002
-
Naldini L, Blomer U, Gage F H. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector[J]. Proc Natl Acad Sci U S A, 1996, 93(): 11382-11388. doi: 10.1073/pnas.93.21.11382
-
Neumann G, Feldmann H, Watanabe S. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture[J]. J Virol, 2002, 76(): 406-410. doi: 10.1128/JVI.76.1.406-410.2002
-
Neumann G, Geisbert T W, Ebihara H. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates[J]. J Virol, 2007, 81(): 2995-2998. doi: 10.1128/JVI.02486-06
-
Pager C T, Craft W W, Patch Jr J. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L[J]. Virology, 2006, 346(): 251-257. doi: 10.1016/j.virol.2006.01.007
-
Qiu Z, Hingley S T, Simmons G. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry[J]. J Virol, 2006, 80(): 5768-5776. doi: 10.1128/JVI.00442-06
-
Saeed M F, Kolokoltsov A A, Albrecht T, et al. 2010. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog, 6 (9).pii: e1001110.
-
Saeed M F, Kolokoltsov A A, Freiberg A N. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus[J]. PLoS Pathog, 2008, 4(): e1000141-. doi: 10.1371/journal.ppat.1000141
-
Sanchez A, Kiley M P, Holloway B P. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus[J]. Virus Res, 1993, 29(): 215-240. doi: 10.1016/0168-1702(93)90063-S
-
Sanchez A, Trappier S G, Mahy B W. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing[J]. Proc Natl Acad Sci U S A, 1996, 93(): 3602-3607. doi: 10.1073/pnas.93.8.3602
-
Sanchez A, Trappier S G, Stroher U. Variation in the glycoprotein and VP35 genes of Marburg virus strains[J]. Virology, 1998, 240(): 138-146. doi: 10.1006/viro.1997.8902
-
Schornberg K, Matsuyama S, Kabsch K. Role of endosomal cathepsins in entry mediated by the ebola virus glycoprotein[J]. J Virol, 2006, 80(): 4174-4178. doi: 10.1128/JVI.80.8.4174-4178.2006
-
Shimojima M, Takada A, Ebihara H. Tyro3 family-mediated cell entry of ebola and marburg viruses[J]. J Virol, 2006, 80(): 10109-10116. doi: 10.1128/JVI.01157-06
-
Simmons G, Gosalia D N, Rennekamp A J. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry[J]. Proc Natl Acad Sci USA, 2005, 102(): 11876-11881. doi: 10.1073/pnas.0505577102
-
Simmons G, Wool-Lewis R J, Baribaud F. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence[J]. J Virol, 2002, 76(): 2518-2528. doi: 10.1128/jvi.76.5.2518-2528.2002
-
Simon J H, Fouchier R A, Southerling T E. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells[J]. J Virol, 1997, 71(): 5259-5267.
-
Takada A, Fujioka K, Tsuiji M. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry[J]. J Virol, 2004, 78(): 2943-2947. doi: 10.1128/JVI.78.6.2943-2947.2004
-
Takada A, Robison C, Goto H. A system for functional analysis of Ebola virus glycoprotein[J]. Proc Natl Acad Sci USA, 1997, 94(): 14764-14769. doi: 10.1073/pnas.94.26.14764
-
Volchkov V E, Becker S, Volchkova V A. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases[J]. Virology, 1995, 214(): 421-430. doi: 10.1006/viro.1995.0052
-
Volchkov V E, Feldmann H, Volchkova V A. Processing of the Ebola virus glycoprotein by the proprotein convertase furin[J]. Proc Natl Acad Sci U S A, 1998, 95(): 5762-5767. doi: 10.1073/pnas.95.10.5762
-
Warren T K, Warfield K L, Wells J. Antiviral activity of a small-molecule inhibitor of filovirus infection[J]. Antimicrob Agents Chemother, 2010, 54(): 2152-2159. doi: 10.1128/AAC.01315-09
-
Wilson J A, Bray M, Bakken R. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins[J]. Virology, 2001, 286(): 384-390. doi: 10.1006/viro.2001.1012
-
Wool-Lewis R, Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor deficient cell lines[J]. J Virol, 1998, 72(): 3155-3160.
-
Wool-Lewis R, Bates P. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function[J]. J Virol, 1999, 73(): 1419-1426.
-
Yang Z Y, Duckers H J, Sullivan N J. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury[J]. Nat Med, 2000, 6(): 886-889. doi: 10.1038/78645
-
Yermolina M V, Wang J, Caffrey M. Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry[J]. J Med Chem, 2011, 54(): 765-781. doi: 10.1021/jm1008715